Polymorphism and signalling of melatonin receptors

被引:33
|
作者
Brydon, L
Petit, L
de Coppet, P
Barrett, P
Morgan, PJ
Strosberg, AD
Jockers, R
机构
[1] CNRS, UPR0415, Inst Cochin Genet Mol, Lab Immunopharmacol Mol, F-75014 Paris, France
[2] Univ Paris 07, F-75014 Paris, France
[3] Rowett Res Inst, Mol Neuroendocrinol Grp, Bucksburn AB2 9SB, Aberdeen, Scotland
来源
REPRODUCTION NUTRITION DEVELOPMENT | 1999年 / 39卷 / 03期
关键词
melatonin receptor; polymorphism; signalling;
D O I
10.1051/rnd:19990304
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Melatonin receptors belong to the superfamily of G protein-coupled receptors. Cloning of Melic receptors expressed in Xenopus skin revealed the existence of a polymorphism for these receptors. Heterologous expression of the two allelic isoforms, called Mel1c(alpha) and Mel1c(beta), indicated functional differences in their signalling properties. Both isoforms are coupled to the cAMP and cGMP pathways. However, the alpha isoform is preferentially coupled to the cAMP pathway, whereas the beta isoform couples preferentially to the cGMP pathway. Coupling differences may be explained by the fact that five of the six amino acid substitutions between the two isoforms are localized within intracellular receptor regions potentially involved in G protein coupling. Allelic isoforms were also observed for Mel1a receptors expressed in ovine pars tuberalis, suggesting that polymorphism is a general feature of the melatonin receptor family. We also evaluated the potential of the two human melatonin receptor subtypes, Mel1a and Mel1b, to modulate the cGMP pathway. Melatonin inhibited intracellular cGMP levels in a dose-dependent manner in HEK293 cells transfected with the human Mel1b receptor. This was not the case for HEK293 cells transfected with the human Mel1a receptor. In conclusion, our results indicate that the expression of receptor subtypes and isoforms may permit differential signalling between melatonin receptors. (C) Inra/Elsevier, Paris.
引用
收藏
页码:315 / 324
页数:10
相关论文
共 50 条
  • [1] Signalling by melatonin receptors
    Petit, L
    Guardiola, B
    Delagrange, P
    Jockers, R
    Strosberg, AD
    THERAPIE, 1998, 53 (05): : 421 - 428
  • [2] Melatonin receptors: molecular pharmacology and signalling in the context of system bias
    Cecon, Erika
    Oishi, Atsuro
    Jockers, Ralf
    BRITISH JOURNAL OF PHARMACOLOGY, 2018, 175 (16) : 3263 - 3280
  • [3] Melatonin and melatonin receptors
    Kowalewska, W
    Kmiec, M
    Kulig, H
    MEDYCYNA WETERYNARYJNA, 2004, 60 (09) : 899 - 901
  • [4] Nuclear signalling of melatonin
    Carlberg, C
    Wiesenberg, I
    Schrader, M
    THERAPEUTIC POTENTIAL OF MELATONIN, 1997, 23 : 25 - 35
  • [5] Dual signalling of melatonin receptors via Gi and Gq proteins in rat uterine myocytes
    Steffens, F
    Sausbier, U
    Zhou, XB
    Ruth, P
    Korth, M
    Wieland, T
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2003, 367 : R22 - R22
  • [6] MELATONIN RECEPTORS
    KRAUSE, DN
    DUBOCOVICH, ML
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1991, 31 : 549 - 568
  • [7] Melatonin in plant signalling and behaviour
    Erland, Lauren A. E.
    Saxena, Praveen K.
    Murch, Susan J.
    FUNCTIONAL PLANT BIOLOGY, 2018, 45 (1-2) : 58 - 69
  • [8] An overview of melatonin and melatonin receptors in birds
    Pang, SF
    Pang, CS
    Poon, AMS
    Wan, Q
    Song, Y
    Brown, GM
    POULTRY AND AVIAN BIOLOGY REVIEWS, 1996, 7 (04): : 217 - 228
  • [9] LOCATION OF MELATONIN RECEPTORS
    LANG, U
    AUBERT, ML
    SIZONENKO, PC
    PEDIATRIC RESEARCH, 1981, 15 (01) : 80 - 80
  • [10] Nuclear melatonin receptors
    Smirnov, AN
    BIOCHEMISTRY-MOSCOW, 2001, 66 (01) : 19 - 26